Suven Pharmaceuticals

BSE : 543064 | NSE : SUVENPHAR
Industry : Pharmaceuticals | ISIN : INE03QK01018 | FreeFloat : 40.00% | FnO : No | LotSize : N/A
Intellectual Capital (IC)7,085.53
Net Worth (NW)1,527.18
Intrinsic Worth (IW)8,612.71
Market Cap (MC)15,743.57
Economic Value Added41.99
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)82.27%
IC Gross Margin (EBITDA/IC)10.68%
IC Net Margin (NPT/IC)6.65%
Knowledge Turnover (Sales/IC)0.20
Market to Intrinsic Value (MC/IW)1.83
As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 338.33Rs. 618.45
26 May 2022 ---- Rs. 503.70
-4.80     -0.95%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 516.15SellAvoid
KB > 50% : Yes50 DMA : Rs. 566.38
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
242.70
242.74
125.66
122.27
119.63
72.49
58.41
Sep-19
C
227.62
235.47
110.35
102.53
96.93
91.53
126.50
Dec-19
C
178.71
183.60
79.65
74.05
71.33
51.55
57.91
Mar-20
C
184.76
190.10
77.34
70.29
68.41
53.21
74.18
Jun-20
C
238.23
243.97
128.14
121.07
117.87
91.52
91.32
Sep-20
C
237.39
237.74
107.60
100.10
96.84
74.08
74.08
Dec-20
C
274.93
279.78
158.99
150.23
147.50
113.63
113.63
Mar-21
C
259.16
262.46
115.65
107.34
105.47
83.12
83.12
Jun-21
C
263.80
269.58
144.04
135.05
132.92
105.08
105.08
Sep-21
C
300.99
306.03
144.28
135.10
133.93
96.98
96.98
Dec-21
C
391.59
456.27
250.71
240.20
239.46
160.07
160.07
Mar-22
C
363.85
380.72
173.89
163.47
161.28
91.67
91.67
* C - Consolidated, S - Standalone